Browse Pet Safety Reports
1,332,683 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 1,332,683 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 1,332,683 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Mar 13, 2026 | Dog | Schnauzer - Miniature | Moxidectin | Lack of efficacy (endoparasite) - hookworm; Medication error NOS; Drug dose a... | Ongoing |
| Mar 13, 2026 | Dog | Spitz - German Pomeranian | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Borrelia | Ongoing |
| Mar 13, 2026 | Dog | Crossbred Canine/dog | Milbemycin Oxime; Praziquantel | Lack of efficacy (endoparasite) - heartworm; Other abnormal test result NOS; ... | Outcome Unknown |
| Mar 13, 2026 | Cat | Cat (unknown) | Bexagliflozin | Lack of efficacy - NOS | Outcome Unknown |
| Mar 13, 2026 | Cat | Domestic Shorthair | Oclacitinib Maleate | Lethargy (see also Central nervous system depression in Neurological); Weak p... | Ongoing |
| Mar 13, 2026 | Dog | Mastiff (unspecified) | Oclacitinib Maleate | Seizure NOS; Urinary incontinence; Walking slowly; Tiredness | Recovered/Normal |
| Mar 12, 2026 | Dog | Retriever - Golden | Lotilaner,Moxidectin,Praziquantel,Pyr... | Lack of efficacy (bacteria) - Anaplasma | Outcome Unknown |
| Mar 12, 2026 | Cat | Domestic Shorthair | Buprenorphine | Not eating; Hypersalivation; Hypoglycaemia; Hypotension; Abnormal ultrasound ... | Ongoing |
| Mar 12, 2026 | Dog | Retriever - Labrador | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (bacteria) - Ehrlichia; Lack of efficacy (ectoparasite) - ti... | Recovered/Normal |
| Mar 12, 2026 | Dog | Unknown | Maropitant Citrate | Lack of efficacy - NOS | Outcome Unknown |
| Mar 12, 2026 | Dog | Retriever - Golden | Meloxicam | Vomiting; Anorexia; Azotaemia; Electrolyte disorder; Hypercortisolaemia; Hype... | Ongoing |
| Mar 12, 2026 | Dog | Crossbred Canine/dog | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Mar 12, 2026 | Dog | Great Pyrenees, Dog (unknown) | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Mar 12, 2026 | Dog | Corgi - Welsh Pembroke | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - hookworm | Ongoing |
| Mar 12, 2026 | Dog | Schnauzer - Miniature | Lotilaner,Moxidectin,Praziquantel,Pyr... | Lack of efficacy (bacteria) - Borrelia | Outcome Unknown |
| Mar 12, 2026 | Dog | Retriever - Labrador | Moxidectin | Lack of efficacy (endoparasite) - hookworm | Ongoing |
| Mar 12, 2026 | Dog | Pointing Dog - German Short... | Afoxolaner 37.5Mg / Moxidectin 180Mcg... | Lack of efficacy (endoparasite) - heartworm | Outcome Unknown |
| Mar 12, 2026 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Lack of efficacy (ectoparasite) - flea; Drug administered at inappropriate site | Ongoing |
| Mar 12, 2026 | Dog | Deutsche Dogge, Great Dane | Sarolaner | Lack of efficacy (endoparasite) - whipworm; Intentional misuse | Ongoing |
| Mar 12, 2026 | Dog | Dachshund (unspecified), Ma... | Ivermectin; Pyrantel As Pamoate Salt | Vomiting | Recovered/Normal |
| Mar 12, 2026 | Dog | Crossbred Canine/dog | Chlorhexidine; Ophytrium | Application site erythema; Application site rash | Ongoing |
| Mar 12, 2026 | Cat | Domestic Shorthair | Frunevetmab | Lethargy (see also Central nervous system depression in Neurological); Not hi... | Recovered/Normal |
| Mar 12, 2026 | Dog | Shepherd Dog - German | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Borrelia | Ongoing |
| Mar 12, 2026 | Dog | Shar Pei | Tigilanol Tiglate | Metastatic neoplasia; Rectal bleeding; Oral bleeding; Death; Rectal prolapse | Died |
| Mar 12, 2026 | Dog | Dog (unknown) | Bedinvetmab | Lethargy (see also Central nervous system depression in Neurological); Weakne... | Euthanized |
| Mar 12, 2026 | Cattle | Aberdeen Angus | Fenbendazol Suspension | Collapse NOS (see also Cardio-vascular and Neurological disorders); Death; Ne... | Died |
| Mar 12, 2026 | Dog | Terrier (unspecified), Coon... | Sarolaner | Vomiting | Recovered/Normal |
| Mar 12, 2026 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Lack of efficacy - NOS | Outcome Unknown |
| Mar 12, 2026 | Dog | Beagle, Dog (unknown) | Afoxolaner 75Mg / Moxidectin 360Mcg /... | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Mar 12, 2026 | - | Unknown | Mirtazapine | Product defect, product difficult to use/handle (see also 'Drug device diffic... | - |
| Mar 12, 2026 | Dog | Dog (unknown) | Fluralaner 13.64% 12-Week Chew | Vomiting | Recovered/Normal |
| Mar 12, 2026 | Dog | Retriever - Golden | Genta/Posacon/Mometa Eardrops | Application site pain; Application site reddening; Application site warmth; A... | Ongoing |
| Mar 12, 2026 | Dog | Poodle (unspecified), Dog (... | Pyrantel Pamoate;Sarolaner | Seizure NOS; Head twitching; Ataxia; Abnormal menace reflex test | Ongoing |
| Mar 12, 2026 | Cattle | Aberdeen Angus | Tulathromycin | Lack of efficacy - NOS | Outcome Unknown |
| Mar 12, 2026 | Dog | Hound - Great Anglo-French ... | Genta/Posacon/Mometa Eardrops | Application site ulcer; Application site inflammation; Application site react... | Ongoing |
| Mar 12, 2026 | Dog | Crossbred Canine/dog, Sheep... | Genta/Posacon/Mometa Eardrops | Lack of efficacy - NOS | Ongoing |
| Mar 12, 2026 | Dog | Great Pyrenees, Dog (unknown) | Milbemycin Oxime; Praziquantel | Lack of efficacy (endoparasite) - heartworm | Outcome Unknown |
| Mar 12, 2026 | Dog | Shiba Inu | Pyrantel Pamoate;Sarolaner | Itching | Ongoing |
| Mar 12, 2026 | Dog | Maltese, Poodle (unspecified) | Spinosad; Milbemycin Oxime | Vomiting | Outcome Unknown |
| Mar 12, 2026 | Dog | Retriever - Labrador, Mount... | Moxidectin | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Mar 12, 2026 | Dog | Retriever - Labrador | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - roundworm NOS | Ongoing |
| Mar 12, 2026 | Dog | Dachshund (unspecified) | Moxidectin | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Mar 12, 2026 | Dog | Crossbred Canine/dog | Oclacitinib Maleate | Lack of efficacy - NOS | Ongoing |
| Mar 12, 2026 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Application site hair loss; Application site itching | Ongoing |
| Mar 12, 2026 | Dog | Shepherd Dog - Australian | Afoxolaner | Shaking; Breathing difficulty; Unable to walk; Fever; Lethargy (see also Cent... | Ongoing |
| Mar 12, 2026 | Dog | Spaniel - Field | Moxidectin | Lack of efficacy (endoparasite) - tapeworm; Medication error NOS | Outcome Unknown |
| Mar 12, 2026 | Dog | Crossbred Canine/dog | Meloxicam | Haematochezia; Anaemia NOS | Outcome Unknown |
| Mar 12, 2026 | Dog | Crossbred Canine/dog, Sheph... | Fluralaner Powder For Inj Susp | Unsteady gait; Trembling; Twitching; Wobbliness; Head bobbing; Incoordination... | Ongoing |
| Mar 12, 2026 | Dog | Retriever - Golden, Shepher... | Sulfadimethoxine | Agitation; Itching; Facial swelling (see also Skin) | Ongoing |
| Mar 12, 2026 | Dog | Poodle (unspecified), Dog (... | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - roundworm NOS | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.